🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Treatment, In combination with BSC, Open-label, Single arm, Efficacy Study....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-01
Trial ID
NCT00542308
Treatments Being Tested
To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-11
Trial ID
NCT00373256
Treatments Being Tested
Individuals with Down syndrome (DS) have an increased risk of numerous co-o...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2023-06-29
Trial ID
NCT05662228
Treatments Being Tested
This is an investigator-initiated clinical trial evaluating the safety, tol...
Status
Active Not Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-12-30
Trial ID
NCT07461181
Treatments Being Tested
M108 is a monoclonal antibody specific for gastric and gastroesophageal ade...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-06-11
Trial ID
NCT04894825
This Phase 1 Study is an open-label, non-randomized, dose escalation, safet...
Status
Completed
Location
Institut Paoli-Calmettes
Start Date
2020-05-29
Trial ID
NCT03957915
Treatments Being Tested
A Phase Ia/II, Multicenter Study to Evaluate the Safety, Tolerability, Phar...
Status
Recruiting
Location
Sir run run shaw Hospital
Start Date
2024-05-15
Trial ID
NCT06868849
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of the res...
Status
Completed
Location
Saint John's Cancer Institute
Start Date
2018-03-01
Trial ID
NCT03425292
V-CHANCE is a phase 2, trial exploring the feasibility and the activity of ...
Status
Unknown
Location
Istituto Nazionale Tumori Fondazione G. Pascale
Start Date
2015-02-23
Trial ID
NCT02624128
Treatments Being Tested
Multiple Sclerosis (MS) is the most common neurological disorder causing di...
Status
Completed
Location
Neurocenter of Southern Switzerland, Ospedale Civico Lugano
Start Date
2010-06
Trial ID
NCT01144052
Treatments Being Tested